Aggregated antibiograms and monitoring of drug-resistant Streptococcus pneumoniae

Emerging Infectious Diseases

Volumn 9, Issue 9, 2003, Pages 1089-1095

  Van Beneden, Chris A ^a,j   Lexau, Catherine ^b   Baughman, Wendy ^c   Barnes, Brenda ^d   Bennett, Nancy ^e   Cassidy, P Maureen ^f   Pass, Margaret ^g   Gelling, Lisa ^h   Barrett, Nancy L ⁱ   Zell, Elizabeth R ^a   Whitney, Cynthia G ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MINNESOTA DEPARTMENT OF HEALTH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e Monroe County Department of Public Health   (United States)

^f OREGON DEPARTMENT OF HUMAN SERVICES   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h CALIFORNIA EMERGING INFECTIONS PROGRAM   (United States)

ⁱ Department of Public Health ^*  (United States)

^j NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ACCURACY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; INFORMATION PROCESSING; INTERMETHOD COMPARISON; LABORATORY TEST; NONHUMAN; STAPHYLOCOCCUS ALBUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0042316906     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0909.020620     Document Type: Article

References (20)

1. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000;343:1917-24.
2. Kaplan SL, Mason EO Jr, Wald E, Tan TQ, Schutze GE, Bradley JS, et al. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J 2002;21:141-7.
3. Kaplan SL, Mason EO Jr. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev 1998;11:628-44.
4. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med 2000;160:1399-408.
5. John CC, Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin Infect Dis 1994;18:188-93.
6. Dagan R, Abramson O, Leibovitz E, Lang R, Goshen S, Greenberg D, et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr Infect Dis J 1996;15:980-5.
7. del Castillo F, Baquero-Artigao F, Garcia-Perea A. Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain. Pediatr Infect Dis J 1998;17:94-7
8. Feikin DR, Schuchat A, Kolczak M, Barrett NL, Harrison LH, Lefkowitz L, et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000;90:223-9.
9. Turett GS, Blum S, Fazal BA, Justman JE, Telzak EE. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence. Clin Infect Dis 1999;29:321-7.
10. Thornsberry C, Sahm DF, Kelly LJ, Critchley IA, Jones ME, Evangelista AT, et al. Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000. Clin Infect Dis 2002;34(Suppl 1):S4-16.
11. Chin AE, Hedberg K, Cieslak PR, Cassidy M, Stefonek KR, Fleming DW. Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method. Emerg Infect Dis 1999;5:688-93.
12. Schuchat A, Hilger T, Zell E, Farley MM, Reingold A, Harrison L, et al. Active Bacterial Core Surveillance of the Emerging Infections Program Network. Emerg Infect Dis 2001;7:92-9.
13. National Committee for Clinical Laboratory Standards. Approved standard M7-A4: standard methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Wayne (PA): The Committee; 1997.
14. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: MI00-S8. Wayne (PA): The Committee; 1998.
15. Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrobial Agents Chemother 2001;45:1721-9.
16. Doern GV, Brueggemann AB, Huynh HK, Wingert E, Rhomberg PR. Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-1998. Emerg Infect Dis 1999;5:757-65.
17. Heffernan R, Henning K, Labowitz A, Hjelte A, Layton M. Laboratory survey of drug-resistant Streptococcus pneumoniae in New York City, 1993-1995. Emerg Infect Dis 1998;4:113-6.
18. Tenover FC, Baker CN, Swenson JM. Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae. J Clin Microbiol 1996;34:10-4.
19. Schrag SJ, Zell ER, Schuchat A, Whitney CG. Sentinel surveillance: a reliable way to track antibiotic resistance in communities? Emerg Infect Dis 2002;8:496-502.
20. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; twelfth informational supplement. NCCLS document M100-S12 (ISBN 1-56238-454-6). Wayne (PA): The Committee; 2002.